Other than the usual patient co-payment, there will be no extra cost to you for Dicarz. Two strategies have been suggested for changing from metoprolol succinate to carvedilol; either a non-overlapping protocol where a straight switch is made, or an over-lapping protocol where the dose of metoprolol succinate is gradually reduced whilst simultaneously up-titrating carvedilol.
Dilatrend will no longer be subsidised.
Initially, quizzes are posted out with journals and GPs are invited to submit their answers for CME credits. This item is 10 years and 2 months old; some content may no longer be current. This article is 10 years and 2 months old. Initial dosing must be low enough to avoid hypotension resulting from vasodilation. The funded brand of carvedilol will change from Dilatrend to Dilanz. Key points Carvedilol may be an option if metoprolol succinate is poorly tolerated.
Critical differences among beta-adrenoreceptor antagonists in myocardial failure: Make a comment Comments There are currently no comments for this article. In heart failure, all beta-blockers are not necessarily equal. A stable heart failure regimen e. Managing blood pressure in primary care An update on managing patients with atrial fibrillation The safe and effective use of dabigatran and warfarin in primary care Beta-blockers for cardiovascular conditions: Strategies for changing to carvedilol Two strategies have been suggested for changing from metoprolol succinate to carvedilol; either a non-overlapping protocol where a straight switch is made, or an over-lapping protocol where the dose of metoprolol succinate is gradually reduced whilst simultaneously up-titrating carvedilol.
The tartrate is available as an immediate release twice or three times daily dosing or a once daily slow release preparation. ACE inhibitor, diuretic, etc must be in place.
Will the medicine work the same?
In this issue Gout - Hit the target A slow death from colchicine Is carvedilol superior to metoprolol in heart failure? It has shown to be effective in the treatment of hypertension, coronary heart disease anti-ischaemic and anti-anginal propertieschronic heart failure and left ventricular dysfunction following acute myocardial infarction.
It has been suggested that metoprolol tartrate should have been titrated to a higher dose up to mg per day. Comparing carvedilol and metoprolol: Recently a decision was made to change the brand of the funded carvedilol. Register to use all the features of this website, including selecting clinical areas of interest, taking part in quizzes and much more. New Zealand solutions to a global problem Vitamin D Vitamin D and calcium supplementation in primary care: Cardiovascular system Medicine indications.
Medsafe, the agency that approves medicine for use in New Zealand, approved Dicarz after carefully considering its safety and effectiveness. If a decision is made to switch from metoprolol succinate to carvedilol there are some important considerations: